Example: Heart Attack

Search clinical trials for: CNI 1493

Total 5 results





    • NCT00950105
      Completed
      Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)
      Conditions: Crohn's Disease
    • NCT00741910
      Completed
      Extension Study of Semapimod 60 mg IV x 3 Days
      Conditions: Crohn's Disease
    • NCT00739986
      Completed
      Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo
      Conditions: Crohn's Disease
    • NCT00740103
      Completed
      Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease
      Conditions: Crohn's Disease
    • NCT00038766
      Terminated
      CNI-1493 for Treatment of Moderate to Severe Crohn's Disease
      Conditions: Crohn Disease
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations